Estrogen can activate the SRC and PI3K/AKT pathways through binding receptors and promote the expression of nonphosphorylated β-linked proteins, thereby enhancing PC-3 cell proliferation, migration, invasion, and tumor formation [25]. The gene discussed is SRC; the disease is neoplasm.